Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?

by David Repáraz, Belén Aparicio, Diana Llopiz, Sandra Hervás-Stubbs, Pablo Sarobe
Published 2022-02-01

Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

by Belén Aparicio, Belén Aparicio, Belén Aparicio, David Repáraz, David Repáraz, David Repáraz, Marta Ruiz, Marta Ruiz, Marta Ruiz, Diana Llopiz, Diana Llopiz, Diana Llopiz, Leyre Silva, Leyre Silva, Leyre Silva, Enric Vercher, Enric Vercher, Enric Vercher, Patrick Theunissen, Patrick Theunissen, Patrick Theunissen, Ibon Tamayo, Ibon Tamayo, Cristian Smerdou, Cristian Smerdou, Ana Igea, Ana Igea, Marta Santisteban, Marta Santisteban, Cristina Gónzalez-Deza, Juan J. Lasarte, Juan J. Lasarte, Sandra Hervás-Stubbs, Sandra Hervás-Stubbs, Sandra Hervás-Stubbs, Pablo Sarobe, Pablo Sarobe, Pablo Sarobe
Published 2022-11-01

623 Notch orchestrates a multifaceted immune evasion program in hepatocellular carcinoma

by Amaia Lujambio, Romain Donne, Brian Brown, Marina Barcena-Varela, Alice Kamphorst, Katherine Lindblad, Marina Ruiz de Galarreta, Ian Liebling, David Repáraz, Melissa Yao, Maxime Dhainaut
Published 2021-11-01

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

by David Repáraz, David Repáraz, David Repáraz, Marta Ruiz, Marta Ruiz, Marta Ruiz, Leyre Silva, Leyre Silva, Leyre Silva, Belén Aparicio, Belén Aparicio, Belén Aparicio, Josune Egea, Josune Egea, Josune Egea, Elizabeth Guruceaga, Elizabeth Guruceaga, Daniel Ajona, Daniel Ajona, Daniel Ajona, Daniel Ajona, Yaiza Senent, Yaiza Senent, Yaiza Senent, Enrique Conde, Enrique Conde, Flor Navarro, Sergio Barace, Diego Alignani, Diego Alignani, Sandra Hervás-Stubbs, Sandra Hervás-Stubbs, Sandra Hervás-Stubbs, Juan José Lasarte, Juan José Lasarte, Diana Llopiz, Diana Llopiz, Diana Llopiz, Pablo Sarobe, Pablo Sarobe, Pablo Sarobe
Published 2022-10-01

Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma

by Leyre Silva, Josune Egea, Lorea Villanueva, Marta Ruiz, Diana Llopiz, David Repáraz, Belén Aparicio, Aritz Lasarte-Cia, Juan José Lasarte, Marina Ruiz de Galarreta, Amaia Lujambio, Bruno Sangro, Pablo Sarobe
Published 2020-11-01

Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy

by Flor Navarro, Noelia Casares, Celia Martín-Otal, Aritz Lasarte-Cía, Marta Gorraiz, Patricia Sarrión, Diana Llopiz, David Reparaz, Nerea Varo, Juan Roberto Rodriguez-Madoz, Felipe Prosper, Sandra Hervás-Stubbs, Teresa Lozano, Juan José Lasarte
Published 2022-12-01

Neoantigens as potential vaccines in hepatocellular carcinoma

by Kathrin Heim, Maike Hofmann, Robert Thimme, Marta Ruiz, Pablo Sarobe, Sandra Hervás-Stubbs, Bruno Sangro, Luigi Buonaguro, Beatrice Cavalluzzo, Angela Mauriello, Maria Tagliamonte, David Repáraz, Enric Vercher, Diana Llopiz, Leyre Silva, Belén Aparicio, Josune Egea, Ibon Tamayo-Uria, Jorge García-Balduz, Carla Castro, Mercedes Iñarrairaegui, Charlotte Rohrer, Catrin Tauber
Published 2022-02-01